VRX up +0.87% percent Today $VRX High is at 133.21
Post# of 193
Posted On: 11/14/2014 11:47:08 AM
VRX up +0.87% percent Today $VRX High is at 133.21 and the Low 131.34 with current volume of 539,926.
Recent News posted below.
Valeant Pharmaceuticals International VRX other info.
http://investorshangout.com/Valeant-Pharmaceu...VRX-53038/
VRX Valeant Pharmaceuticals International Recent Headline News
Valeant Should Drop Allergan Bid And Go For Zoetis
Kanak Kanti De - at Seeking Alpha - Fri Nov 14, 7:30AM CST
ZTS: 43.07 (-0.17), AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 4:28PM CST
A report from Bloomberg stated that Actavis is in discussions to Allergan for a deal worth at least $60 billion.
ZTS: 43.07 (-0.17), AGN: 197.17 (+0.96), ACT: 243.26 (+1.63), VRX: 133.21 (+1.31)
Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey
CNW Group - Thu Nov 13, 4:00PM CST
Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy
VRX: 133.21 (+1.31), VRX.TO: 150.54 (+0.39)
Allergan buyout said nearing
at Investor's Business Daily - Wed Nov 12, 5:51PM CST
Drugmaker Actavis (ACT) is reportedly near a deal to take over Botox maker Allergan (AGN) for at least $60 bil. An agreement could be reached in a matter of weeks, said Bloomberg sources. But in order to avoid a looming hostile takeover bid from...
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Actavis, Allergan Reported Near Deal As Valeant Lurks
at Investor's Business Daily - Wed Nov 12, 11:43AM CST
The drug-industry rumor mill got a fresh surge of energy Wednesday on a report that emerging drug giant Actavis (ACT) is nearing a deal to buy Botox maker Allergan (AGN) for at least $60 billion. Reports that the two companies were talking have been...
ZTS: 43.07 (-0.17), AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Cramer Says Zoetis Could Be Next M&A Target for Ackman, Valeant
at The Street - Wed Nov 12, 10:37AM CST
Bill Ackman has a stake in Valeant Pharmaceuticals, as well as Zoetis, the latter of which may become a takeover target by the former, Jim Cramer says.
ZTS: 43.07 (-0.17), VRX: 133.21 (+1.31)
Today's Market: Mergers, Rumors And Earnings Moving These Stocks
Matthew Smith - at Seeking Alpha - Wed Nov 12, 10:04AM CST
ZTS: 43.08 (-0.16), T: 35.81 (+0.20), VRX: 133.21 (+1.31), FOSL: 106.87 (-2.94), BBT: 37.67 (+0.09), PFE: 30.30 (-0.12), KORS: 71.57 (+0.83), SUSQ: 13.14 (+0.08)
Bill Ackman's Latest Target: Zoetis Inc.
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 12, 9:40AM CST
Source: Zoetis. Pershing Square's Bill Ackman is probably best known for his relentless advocacy regarding his short position in Herbalife , but he's also captured a lot of attention this year as being a key voice of support for the sale of ...
ZTS: 43.08 (-0.16), AGN: 197.17 (+0.96), HLF: 37.53 (-0.32), VRX: 133.21 (+1.31), PFE: 30.30 (-0.12), MRK: 58.96 (-0.58), LLY: 67.48 (-0.20)
Allergan tweaks bylaws pertaining to special meeting requests
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 7:07AM CST
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 133.21 (+1.31), MDT: 69.07 (-0.31), C: 53.40 (-0.04), WMT: 82.43 (-0.51), RBS: 11.78 (+0.03), UBS: 17.52 (-0.02), NOK: 7.82 (-0.44), YHOO: 51.06 (+0.56), PBR: 9.64 (-0.56), SPY: 204.20 (+0.01), SAP: 66.52 (-0.11), EBAY: 54.38 (+0.01), JPM: 60.50 (+0.27), BHP: 57.78 (+0.15), AAPL: 113.95 (+1.13), BCS: 14.55 (+0.12), FRM: 6.23 (-0.03), COV: 93.85 (+0.18), HSBC: 50.21 (+0.06), FRGI: 56.74 (+0.31), ZTS: 43.08 (-0.16), DLA: 10.45 (-0.10), QQQ: 103.09 (+0.19), AOL: 46.53 (+0.16), BABA: 114.78 (-0.06)
Bill Ackman vs. Allergan, Inc.: Who Will Win the War of Words?
George Budwell, The Motley Fool - Motley Fool - Tue Nov 11, 5:18PM CST
Irvine, Calif.-based Botox maker Allergan is desperately trying to fend off a takeover bid from Valeant Pharmaceuticals , a company with a history of buying rivals and slashing their work forces. In an interesting twist, this deal is being...
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Zoetis could be fallback option for Valeant
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:16PM CST
AGN: 197.17 (+0.96), ZTS: 43.08 (-0.16), ACT: 243.26 (+1.63), VRX: 133.21 (+1.31)
Zoetis jumps 6% on report of Ackman stake
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 2:48PM CST
ZTS: 43.08 (-0.16), VRX: 133.21 (+1.31)
Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.76 (+0.01), AGN: 197.17 (+0.96), ACT: 243.26 (+1.63), VRX: 133.21 (+1.31), MDT: 69.07 (-0.31), SLXP: 99.53 (+2.54), SNY: 46.42 (-0.11)
Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 89.18 (+0.10), VRX: 133.21 (+1.31), ALXN: 189.17 (-4.42), AMGN: 158.43 (-2.42), MYL: 53.86 (-0.87), ILMN: 180.14 (-4.86), CELG: 103.74 (-3.69)
Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Mon Nov 10, 1:56PM CST
Salix's (SLXP) wholesale inventory levels for its products were much higher than previously announced.
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), AUXL: 32.25 (-0.10), SLXP: 99.53 (+2.54)
Valeant Pharmaceuticals Sends Letter To Physician Customers
CNW Group - Fri Nov 07, 4:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today sent a letter to physician customers in order to address misconceptions and clarify how Valeant operates its business.
VRX: 133.21 (+1.31), VRX.TO: 150.54 (+0.39)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), DVA: 77.34 (+0.30), GILD: 102.26 (-1.94), SLXP: 99.53 (+2.54), ICPT: 159.07 (+0.21), HUM: 137.35 (-1.06)
Recent News posted below.
Valeant Pharmaceuticals International VRX other info.
http://investorshangout.com/Valeant-Pharmaceu...VRX-53038/
VRX Valeant Pharmaceuticals International Recent Headline News
Valeant Should Drop Allergan Bid And Go For Zoetis
Kanak Kanti De - at Seeking Alpha - Fri Nov 14, 7:30AM CST
ZTS: 43.07 (-0.17), AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 4:28PM CST
A report from Bloomberg stated that Actavis is in discussions to Allergan for a deal worth at least $60 billion.
ZTS: 43.07 (-0.17), AGN: 197.17 (+0.96), ACT: 243.26 (+1.63), VRX: 133.21 (+1.31)
Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey
CNW Group - Thu Nov 13, 4:00PM CST
Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy
VRX: 133.21 (+1.31), VRX.TO: 150.54 (+0.39)
Allergan buyout said nearing
at Investor's Business Daily - Wed Nov 12, 5:51PM CST
Drugmaker Actavis (ACT) is reportedly near a deal to take over Botox maker Allergan (AGN) for at least $60 bil. An agreement could be reached in a matter of weeks, said Bloomberg sources. But in order to avoid a looming hostile takeover bid from...
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Actavis, Allergan Reported Near Deal As Valeant Lurks
at Investor's Business Daily - Wed Nov 12, 11:43AM CST
The drug-industry rumor mill got a fresh surge of energy Wednesday on a report that emerging drug giant Actavis (ACT) is nearing a deal to buy Botox maker Allergan (AGN) for at least $60 billion. Reports that the two companies were talking have been...
ZTS: 43.07 (-0.17), AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Cramer Says Zoetis Could Be Next M&A Target for Ackman, Valeant
at The Street - Wed Nov 12, 10:37AM CST
Bill Ackman has a stake in Valeant Pharmaceuticals, as well as Zoetis, the latter of which may become a takeover target by the former, Jim Cramer says.
ZTS: 43.07 (-0.17), VRX: 133.21 (+1.31)
Today's Market: Mergers, Rumors And Earnings Moving These Stocks
Matthew Smith - at Seeking Alpha - Wed Nov 12, 10:04AM CST
ZTS: 43.08 (-0.16), T: 35.81 (+0.20), VRX: 133.21 (+1.31), FOSL: 106.87 (-2.94), BBT: 37.67 (+0.09), PFE: 30.30 (-0.12), KORS: 71.57 (+0.83), SUSQ: 13.14 (+0.08)
Bill Ackman's Latest Target: Zoetis Inc.
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 12, 9:40AM CST
Source: Zoetis. Pershing Square's Bill Ackman is probably best known for his relentless advocacy regarding his short position in Herbalife , but he's also captured a lot of attention this year as being a key voice of support for the sale of ...
ZTS: 43.08 (-0.16), AGN: 197.17 (+0.96), HLF: 37.53 (-0.32), VRX: 133.21 (+1.31), PFE: 30.30 (-0.12), MRK: 58.96 (-0.58), LLY: 67.48 (-0.20)
Allergan tweaks bylaws pertaining to special meeting requests
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 7:07AM CST
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 133.21 (+1.31), MDT: 69.07 (-0.31), C: 53.40 (-0.04), WMT: 82.43 (-0.51), RBS: 11.78 (+0.03), UBS: 17.52 (-0.02), NOK: 7.82 (-0.44), YHOO: 51.06 (+0.56), PBR: 9.64 (-0.56), SPY: 204.20 (+0.01), SAP: 66.52 (-0.11), EBAY: 54.38 (+0.01), JPM: 60.50 (+0.27), BHP: 57.78 (+0.15), AAPL: 113.95 (+1.13), BCS: 14.55 (+0.12), FRM: 6.23 (-0.03), COV: 93.85 (+0.18), HSBC: 50.21 (+0.06), FRGI: 56.74 (+0.31), ZTS: 43.08 (-0.16), DLA: 10.45 (-0.10), QQQ: 103.09 (+0.19), AOL: 46.53 (+0.16), BABA: 114.78 (-0.06)
Bill Ackman vs. Allergan, Inc.: Who Will Win the War of Words?
George Budwell, The Motley Fool - Motley Fool - Tue Nov 11, 5:18PM CST
Irvine, Calif.-based Botox maker Allergan is desperately trying to fend off a takeover bid from Valeant Pharmaceuticals , a company with a history of buying rivals and slashing their work forces. In an interesting twist, this deal is being...
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), ACT: 243.26 (+1.63)
Zoetis could be fallback option for Valeant
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:16PM CST
AGN: 197.17 (+0.96), ZTS: 43.08 (-0.16), ACT: 243.26 (+1.63), VRX: 133.21 (+1.31)
Zoetis jumps 6% on report of Ackman stake
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 2:48PM CST
ZTS: 43.08 (-0.16), VRX: 133.21 (+1.31)
Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.76 (+0.01), AGN: 197.17 (+0.96), ACT: 243.26 (+1.63), VRX: 133.21 (+1.31), MDT: 69.07 (-0.31), SLXP: 99.53 (+2.54), SNY: 46.42 (-0.11)
Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 89.18 (+0.10), VRX: 133.21 (+1.31), ALXN: 189.17 (-4.42), AMGN: 158.43 (-2.42), MYL: 53.86 (-0.87), ILMN: 180.14 (-4.86), CELG: 103.74 (-3.69)
Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Mon Nov 10, 1:56PM CST
Salix's (SLXP) wholesale inventory levels for its products were much higher than previously announced.
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), AUXL: 32.25 (-0.10), SLXP: 99.53 (+2.54)
Valeant Pharmaceuticals Sends Letter To Physician Customers
CNW Group - Fri Nov 07, 4:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today sent a letter to physician customers in order to address misconceptions and clarify how Valeant operates its business.
VRX: 133.21 (+1.31), VRX.TO: 150.54 (+0.39)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 197.17 (+0.96), VRX: 133.21 (+1.31), DVA: 77.34 (+0.30), GILD: 102.26 (-1.94), SLXP: 99.53 (+2.54), ICPT: 159.07 (+0.21), HUM: 137.35 (-1.06)
(0)
(0)Bausch Health Companies Inc. (BHC) Stock Research Links
Scroll down for more posts ▼